AIDS-related mycoses: the way forward
- PMID: 24581941
- PMCID: PMC4129449
- DOI: 10.1016/j.tim.2013.12.008
AIDS-related mycoses: the way forward
Abstract
The contribution of fungal infections to the morbidity and mortality of HIV-infected individuals is largely unrecognized. A recent meeting highlighted several priorities that need to be urgently addressed, including improved epidemiological surveillance, increased availability of existing diagnostics and drugs, more training in the field of medical mycology, and better funding for research and provision of treatment, particularly in developing countries.
Keywords: AIDS; HIV; fungal infection; immunity; mortality; translational research.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Figures
References
-
- Brown GD, et al. Tackling human fungal infections. Science. 2012;336:647. - PubMed
-
- Brown GD, et al. Human fungal infections: the hidden killers. Sci Transl Med. 2012;4:165rv113. - PubMed
-
- Park BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525–530. - PubMed
-
- Armstrong-James D, et al. A neglected epidemic: fungal infections in HIV/AIDS. Trends Microbiol. 2014;22:120–127. - PubMed
-
- Loyse A, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13:629–637. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
